The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Oxidative stress and regulated cell death in Parkinson’s disease
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. Motor deficits usually associated with PD correlate with dopaminergic axonal neurodegeneration starting at the striatum, which is then followed by dopaminergic neuronal death in the substantia nigra pars compacta (SN), with both events occurring already at the prodromal stage. We will overview the main physiological characteristics responsible for the higher susceptibility of the nigrostriatal circuit to mitochondrial dysfunction and oxidative stress, as determined from the acting mechanisms of the PD-causing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Then, we will present multiple lines of evidence linking several cell death mechanisms involving mitochondria and production of reactive oxygen species to neuronal loss in PD, namely intrinsic and extrinsic apoptosis, necroptosis, ferroptosis, parthanatos and mitochondrial permeability transition-driven necrosis. We will focus on gathered data from postmortem PD samples and relevant in vivo models, especially MPTP-based models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
Rohde, K., Kleinesudeik, L., Roesler, S., Löwe, O., Heidler, J., Schröder, K., Wittig, I., Dröse, S., & Fulda, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.102 · Cited by 64
Moriwaki, K., Balaji, S., Bertin, J., Gough, P. J., & Chan, F. K.-M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.015 · Cited by 64
Apoptosis‐inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins
Perier, C., Bové, J., Dehay, B., Jackson-Lewis, V. R., Rabinovitch, P. S., Przedborski, S., & Vila, M. (2010) · Annals of Neurology · doi:10.1002/ana.22034 · Cited by 62
Thomas, B., Banerjee, R., Starkova, N. N., Zhang, S. F., Calingasan, N. Y., Yang, L., Wille, E. J., Lorenzo, B. J., Ho, D. J., Beal, M. F., et al. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3849 · Cited by 60
Fabre, E., Monserrat, J., Herrero, A., Barja, G., & Leret, M. L. (1999) · Journal of Physiology and Biochemistry · doi:10.1007/bf03655585 · Cited by 60
Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease
Nido, G. S., Dölle, C., Flønes, I. H., Tuppen, H. A. L., Alves, G. W., Tysnes, O., Haugarvoll, K., & Tzoulis, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.024 · Cited by 58
Shamoto‐Nagai, M., Hisaka, S., Naoi, M., & Maruyama, W. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-25 · Cited by 57
Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites
McNamara, D. E., Dovey, C. M., Hale, A. T., Quarato, G., Grace, C. R., Guibao, C. D., Diep, J., Nourse, A., Cai, C., Wu, H., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.03.010 · Cited by 56
Kinase domain dimerization drives RIPK3-dependent necroptosis
Raju, S., Whalen, D. M., Mengistu, M., Swanson, C. J., Quinn, J. G., Taylor, S. S., Webster, J. D., Newton, K., & Shaw, A. S. (2018) · Science Signaling · doi:10.1126/scisignal.aar2188 · Cited by 53
The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics
Seo, J., Kim, M. W., Bae, K., Lee, S. C., Song, J., & Lee, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.012 · Cited by 52
Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease
Landau, A. M., Luk, K. C., Jones, M.-L., Siegrist‐Johnstone, R., Young, Y. K., Kouassi, É., Rymar, V. V., Dagher, A., Sadikot, A. F., & Desbarats, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050163 · Cited by 50
Yokoyama, H., Kuroiwa, H., Tsukada, T., Uchida, H., Kato, H., & Araki, T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22310 · Cited by 48
Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease
Leng, A., Mura, A., Feldon, J., & Ferger, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.077 · Cited by 46
Palin, E., Paetau, A. E., & Suomalainen, A. (2013) · Brain · doi:10.1093/brain/awt160 · Cited by 46
Wu, X., Wang, P., Liu, Y., & Xue, Y. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0175-5 · Cited by 45
Advances in The Use of Parp Inhibitors For Brca1/2-Associated Breast Cancer: Talazoparib
McCann, K. E. (2019) · Future Oncology · doi:10.2217/fon-2018-0751 · Cited by 41
Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
Dionísio, P. A., Oliveira, S. R., Gaspar, M. M., Gama, M. J., Castro‐Caldas, M., Amaral, J. D., & Rodrigues, C. M. P. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2078-z · Cited by 40
Self-citationvan Diggelen, F., Hrle, D., Apetri, M. M., Christiansen, G., Rammes, G., Tepper, A. W. J. W., & Otzen, D. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213663 · Cited by 36
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Morizane, A. (2019) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001235 · Cited by 30
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Qian, L., Zhu, Y., Deng, C., Liang, Z., Chen, J., Chen, Y., Wang, X., Liu, Y., Tian, Y., & Yang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01756-w · Cited by 338
Oxidative stress and mitochondrial impairment: Key drivers in neurodegenerative disorders
Wen, P., Sun, Z., Gou, F., Wang, J., Fan, Q., Zhao, D., & Yang, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102667 · Cited by 253
Wei, Y., Miao, Q., Zhang, Q., Mao, S., Li, M., Xu, X., Xia, X., Wei, K., Fan, Y., Zheng, X., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01476-4 · Cited by 153
“Excessive ROS can oxidize lipids, proteins and nucleic acids, resulting in irreversible damage to neurons 9,10 .”
Background
Metadata
- Authors
- Dionísio, P. A., Amaral, J. D., & Rodrigues, C. M. P.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 67
- Pages
- 101263
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W3129009349
- Cited by
- 424
- References
- 220
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.